Correlation Between ESSA Pharma and Telomir Pharmaceuticals,

Can any of the company-specific risk be diversified away by investing in both ESSA Pharma and Telomir Pharmaceuticals, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ESSA Pharma and Telomir Pharmaceuticals, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ESSA Pharma and Telomir Pharmaceuticals, Common, you can compare the effects of market volatilities on ESSA Pharma and Telomir Pharmaceuticals, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ESSA Pharma with a short position of Telomir Pharmaceuticals,. Check out your portfolio center. Please also check ongoing floating volatility patterns of ESSA Pharma and Telomir Pharmaceuticals,.

Diversification Opportunities for ESSA Pharma and Telomir Pharmaceuticals,

0.45

Correlation Coefficient

ESSA Pharma  Telomir Pharmaceuticals,

Very weak diversification

The 3 months correlation between ESSA and Telomir is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding ESSA Pharma and Telomir Pharmaceuticals, Commo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telomir Pharmaceuticals, and ESSA Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ESSA Pharma are associated (or correlated) with Telomir Pharmaceuticals,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telomir Pharmaceuticals, has no effect on the direction of ESSA Pharma i.e., ESSA Pharma and Telomir Pharmaceuticals, go up and down completely randomly.

Pair Corralation between ESSA Pharma and Telomir Pharmaceuticals,

Given the investment horizon of 90 days ESSA Pharma is expected to under-perform the Telomir Pharmaceuticals,. In addition to that, ESSA Pharma is 1.29 times more volatile than Telomir Pharmaceuticals, Common. It trades about -0.11 of its total potential returns per unit of risk. Telomir Pharmaceuticals, Common is currently generating about -0.02 per unit of volatility. If you would invest  624.00  in Telomir Pharmaceuticals, Common on September 25, 2024 and sell it today you would lose (158.00) from holding Telomir Pharmaceuticals, Common or give up 25.32% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

ESSA Pharma  vs.  Telomir Pharmaceuticals, Commo

ESSA Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ESSA Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Telomir Pharmaceuticals,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Telomir Pharmaceuticals, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's essential indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with ESSA Pharma and Telomir Pharmaceuticals,

The main advantage of trading using opposite ESSA Pharma and Telomir Pharmaceuticals, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ESSA Pharma position performs unexpectedly, Telomir Pharmaceuticals, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telomir Pharmaceuticals, will offset losses from the drop in Telomir Pharmaceuticals,'s long position.

The idea behind ESSA Pharma and Telomir Pharmaceuticals, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.